EyePoint, Inc.
NASDAQEyePoint Pharmaceuticals has bounced 11.6% this week to $14.38, yet the persistent weight of heavy short positioning and a notable shift in options sentiment means this recovery is happening against an unconvinced market backdrop. The positioning picture is a study in contradictions. Short interest at nearly 19% of the free float — up around 6.5% over the past month to roughly 15.6…
Snapshot as of 24 Jun 2026
EyePoint Pharmaceuticals has bounced 11.6% this week to $14.38, yet the persistent weight of heavy short positioning and a notable shift in options sentiment means this recovery is happening against an unconvinced…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EYPT — free to start on ORTEX.
Sign up for free →Open EYPT on ORTEX